Patents by Inventor David Clemmons

David Clemmons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10947285
    Abstract: The present technology generally relates to peptides of IGFBP-2 that may be used to improve bone disorders. The present technology also generally relates to uses of such peptides in methods for preventing or treating bone disorders and to compositions for such uses.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: March 16, 2021
    Assignee: Amolyt Pharma
    Inventors: David Clemmons, Gang Xi, Thomas Delale, Michel Julien, Thierry Abribat
  • Publication number: 20190359676
    Abstract: The present technology generally relates to compounds, in particular peptides comprising the heparin-binding domain (HBD) of insulin-like growth factor binding protein-2 (IGFBP-2) for the modulation of metabolic disorders. The present technology also generally relates to uses of such compounds in methods for preventing and/or treating metabolic disorders and in compositions and formulations for such uses.
    Type: Application
    Filed: May 23, 2019
    Publication date: November 28, 2019
    Inventors: Thomas DELALE, Stephane MILANO, Thierry ABRIBAT, David CLEMMONS
  • Publication number: 20190352358
    Abstract: The present technology generally relates to peptides of IGFBP-2 that may be used to improve bone disorders. The present technology also generally relates to uses of such peptides in methods for preventing or treating bone disorders and to compositions for such uses.
    Type: Application
    Filed: February 5, 2018
    Publication date: November 21, 2019
    Inventors: David CLEMMONS, Gang XI, Thomas DELALE, Michel JULIEN, Thierry ABRIBAT
  • Publication number: 20180230191
    Abstract: The present technology generally relates to peptides of IGFBP-2 that may be used to improve bone disorders. The present technology also generally relates to uses of such peptides in methods for preventing or treating bone disorders and to compositions for such uses.
    Type: Application
    Filed: February 5, 2018
    Publication date: August 16, 2018
    Inventors: David Clemmons, Gang Xi, Thomas Delale, Michel Julien, Thierry Abribat
  • Publication number: 20180016340
    Abstract: The present invention provides an antibody or antigen-binding fragment thereof that binds ?v?3 integrin, as well as methods of use in the treatment of diseases and disorders.
    Type: Application
    Filed: February 22, 2017
    Publication date: January 18, 2018
    Inventors: David CLEMMONS, Laura Maile, Michael Naso, Francis J. Carr, Timothy D. Jones, Simon Willam Keen
  • Patent number: 9587024
    Abstract: The present invention provides an antibody or antigen-binding fragment thereof that binds ?v?3 integrin, as well as methods of use in the treatment of diseases and disorders.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: March 7, 2017
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: David Clemmons, Laura Maile, Michael Naso, Francis J. Carr, Timothy D. Jones, Simon William Keen
  • Publication number: 20160039897
    Abstract: The present invention provides peptides and peptide compositions and methods of their controlling body weight and treating obesity.
    Type: Application
    Filed: March 12, 2014
    Publication date: February 11, 2016
    Inventor: David Clemmons
  • Publication number: 20150259422
    Abstract: The present invention provides an antibody or antigen-binding fragment thereof that binds ?v?3 integrin, as well as methods of use in the treatment of diseases and disorders.
    Type: Application
    Filed: June 2, 2015
    Publication date: September 17, 2015
    Inventors: David CLEMMONS, Laura Maile, Michael Naso, Francis J. Carr, Timothy D. Jones, Simon William Keen
  • Patent number: 9073996
    Abstract: The present invention provides an antibody or antigen-binding fragment thereof that binds ?V?3 integrin, as well as methods of use in the treatment of diseases and disorders.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: July 7, 2015
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: David Clemmons, Laura Maile, Michael Naso, Francis J. Carr, Timothy D. Jones, Simon William Keen
  • Publication number: 20140072568
    Abstract: The present invention provides an antibody or antigen-binding fragment thereof that binds ?V?3 integrin, as well as methods of use in the treatment of diseases and disorders.
    Type: Application
    Filed: August 30, 2013
    Publication date: March 13, 2014
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: David Clemmons, Laura Maile, Michael Naso, Francis J. Carr, Timothy D. Jones, Simon William Keen
  • Publication number: 20070277745
    Abstract: An animal containment system for use in housing animals, the animal containment system including a floor pan disposed in a first plane, first and second end walls, each said end wall oppositely disposed from each other and including a bottom edge and a top edge, a back wall including a bottom edge and a top edge, two doors, each including a bottom edge and a top edge, oppositely disposed from the back wall arranged to cover the open front portion of said animal containment system, a top panel oppositely disposed from the floor pan, a shelf disposed in between the floor pan and top panel, a wire ladder extending between the floor pan and said shelf, and a wheel base assembly comprising a base panel, four support tubes and at least four removable caster wheels.
    Type: Application
    Filed: May 30, 2007
    Publication date: December 6, 2007
    Inventors: David Clemmons, James Wingate, Bryan Jennings, William Kerr, Thomas Swan, Robert Dale
  • Publication number: 20050288217
    Abstract: The present invention provides ?V?3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.
    Type: Application
    Filed: May 6, 2005
    Publication date: December 29, 2005
    Inventors: David Clemmons, Laura Maile